Login / Signup

Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene.

Julia FeldenBritta BaumannManir AliIsabelle AudoCarmen AyusoBeatrice BocquetIngele CasteelsBlanca Garcia-SandovalSamuel G JacobsonBernhard JurkliesUlrich KellnerLine KesselBirgit LorenzMartin McKibbinIsabelle MeunierThomy de RavelThomas RosenbergKlaus RütherMaria VadalaBernd WissingerKatarina StinglSusanne Kohl
Published in: Human mutation (2019)
Achromatopsia (ACHM) is a hereditary cone photoreceptor disorder characterized by the inability to discriminate colors, nystagmus, photophobia, and low-visual acuity. Six genes have been associated with this rare autosomal recessively inherited disease, including the GNAT2 gene encoding the catalytic α-subunit of the G-protein transducin which is expressed in the cone photoreceptor outer segment. Out of a cohort of 1,116 independent families diagnosed with a primary clinical diagnosis of ACHM, we identified 23 patients with ACHM from 19 independent families with likely causative mutations in GNAT2, representing 1.7% of our large ACHM cohort. In total 22 different potentially disease-causing variants, of which 12 are novel, were identified. The mutation spectrum also includes a novel copy number variation, a heterozygous duplication of exon 4, of which the breakpoint matches exactly that of the previously reported exon 4 deletion. Two patients carry just a single heterozygous variant. In addition to our previous study on GNAT2-ACHM, we also present detailed clinical data of these patients.
Keyphrases
  • copy number
  • genome wide
  • end stage renal disease
  • mitochondrial dna
  • ejection fraction
  • peritoneal dialysis
  • prognostic factors
  • early onset
  • machine learning
  • electronic health record
  • genome wide identification